November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Pilot Trial Tests Hyperbaric Oxygen Therapy Following Cardiac Arrest

🔬 Research 2 min read 👁 4

Researchers have completed a preliminary randomized controlled trial assessing hyperbaric oxygen therapy in patients following out-of-hospital cardiac arrest, healthy volunteers, and long-term survivors. The study found the approach feasible and safe, though larger trials are needed to determine clinical effectiveness.

🔬Research

Key points

  • HOT-RESUS 1 trial tested HBOT across ICU patients, survivors, and healthy volunteers
  • All 45 participants completed assigned sessions with zero treatment-related adverse events
  • Small sample size and inconclusive group comparisons mean further trials are required

A recent pilot study published in Nature Health Sciences, known as HOT-RESUS 1, evaluated the feasibility, tolerability, and early biological signals of hyperbaric oxygen therapy (HBOT) following out-of-hospital cardiac arrest. Conducted by an international team of researchers, the prospective, single-centre trial enrolled a total of 45 participants across three distinct groups: intensive care unit patients who achieved a sustained return of spontaneous circulation, long-term cardiac arrest survivors, and healthy volunteers. Participants were randomized to receive no HBOT, a single session, or five sessions.

The study successfully met its recruitment and completion targets, with all assigned treatment sessions finished and no HBOT-related adverse events reported. In acute intensive care patients, serial biomarkers tracked significant temporal changes across inflammatory, oxidative stress, and injury domains, though direct comparisons between treatment groups remained largely inconclusive. Exploratory assessments in long-term survivors and healthy volunteers pointed toward potential improvements in arterial stiffness, alongside favorable numerical patterns in neurocognitive and patient-reported outcomes for those exposed to HBOT.

What to know: While the findings demonstrate that administering hyperbaric oxygen therapy is feasible and safe in these patient cohorts, the small sample size and exploratory nature mean the results cannot confirm clinical efficacy. Readers should consult qualified medical professionals regarding individual health decisions.

The findings identify possible biological and functional outcomes for further investigation in adequately powered randomized trials, though current data preclude definitive conclusions on efficacy.

Limitations of the trial include its small pilot sample size, extensive multiplicity, and largely inconclusive direct between-group comparisons. These factors highlight the preliminary nature of the data, requiring larger, adequately powered randomized controlled trials before any therapeutic recommendations can be established.

Source Nature Health Sciences — nature.com/articles/s41598-026-76474-0 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.